PSTX
Poseida Therapeutics, Inc. Common Stock
PSTX
PSTX
Delisted
PSTX was delisted on the 7th of January, 2025.
115 hedge funds and large institutions have $519M invested in Poseida Therapeutics, Inc. Common Stock in 2024 Q4 according to their latest regulatory filings, with 45 funds opening new positions, 31 increasing their positions, 27 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
15% more repeat investments, than reductions
Existing positions increased: 31 | Existing positions reduced: 27
67% less call options, than puts
Call options by funds: $1.45M | Put options by funds: $4.36M
Holders
115
Holding in Top 10
2
Calls
$1.45M
Puts
$4.36M
Top Buyers
| 1 | +$26.7M | |
| 2 | +$13.8M | |
| 3 | +$10.5M | |
| 4 |
TAL
TIG Advisors LLC
New York
|
+$3.58M |
| 5 |
GCL
Glazer Capital LLC
New York
|
+$2.72M |
Top Sellers
| 1 | -$23.8M | |
| 2 | -$14M | |
| 3 | -$10.7M | |
| 4 |
Renaissance Technologies
New York
|
-$3.27M |
| 5 |
William Blair & Company
Chicago,
Illinois
|
-$3.18M |